RxDoctor Payments Data

Racha Bazzi

Family · Dearborn, MINPI 1679274500

Payments from drug & device makers

$2,233in general payments, 2019–2025

Across 113 payments — averaging $19.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$511
  • AbbVie$246
  • Boehringer Ingelheim$223
  • Lilly USA, LLC$209
  • Exact Sciences$168
  • Pfizer$98
  • plus $778 from 18 others

What the payments were for

  • Food & beverage$2,233100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,233 in reported general payments places this provider in the 80th percentile of 3,657 family providers in Michigan.

See all family providers in Michigan

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide72$45,145
JardianceEmpagliflozin49$40,508
Diclofenac Sodium83$33,837
Trelegy ElliptaFluticasone/Umeclidin/Vilanter42$32,500
EliquisApixaban41$31,109
JanuviaSitagliptin Phosphate40$28,528
TradjentaLinagliptin19$14,034
FarxigaDapagliflozin Propanediol12$13,296
TrintellixVortioxetine Hydrobromide20$9,487
Incruse ElliptaUmeclidinium Bromide13$5,601
Spiriva HandihalerTiotropium Bromide11$5,563
Breo ElliptaFluticasone/Vilanterol13$5,102
Ventolin HfaAlbuterol Sulfate89$5,089
Fluticasone-SalmeterolFluticasone Propion/Salmeterol23$5,087
Albuterol Sulfate HfaAlbuterol Sulfate132$4,764

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$223$54,54268 claims
AbbVieLinzess$246$45,14572 claims
GSKTrelegy Ellipta, Incruse Ellipta, Breo Ellipta$72$43,20368 claims
PfizerEliquis$98$31,10941 claims
MerckJanuvia$67$28,52840 claims
AstraZenecaFarxiga$511$13,29612 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$53$9,48720 claims
Sanofi-aventis U.S. LLCLantus$19$72511 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$17$53363 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,657 family providers in Michigan.

Other family in Dearborn

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →